Forecast: Import of Medicaments for Therapeutic, Prophylactic Use, in Dosage to Canada

In 2023, the import of medicaments for therapeutic, prophylactic use in dosage to Canada was valued at approximately 8.5600 billion US dollars. The forecast for the subsequent years indicates a consistent upward trend: 8.6562 billion in 2024, 8.7531 billion in 2025, 8.8481 billion in 2026, 8.9412 billion in 2027, and 9.0324 billion in 2028. This demonstrates a steady increase in demand, with year-on-year growth averaging around 1% per annum. Over the last five years, the compound annual growth rate (CAGR) highlights a similar trend, emphasizing a modest but stable increase in import values.

Future trends to watch for include:

• Potential regulatory changes in health and pharmaceutical policies.
• The impact of technological advancements and innovation in the pharmaceutical industry.
• Changes in the global supply chain dynamics affecting the availability and cost of imports.
• Shifts in public health priorities and the emergence of new therapeutic needs.